Skip to main content
Clinical Trials/NCT04011865
NCT04011865
Unknown
Not Applicable

Robot-assisted vs Laparoscopic Radical Prostatectomy for Prostate Cancer Treatment

Binh Dan Hospital1 site in 1 country80 target enrollmentJanuary 1, 2019
ConditionsProstate Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Prostate Cancer
Sponsor
Binh Dan Hospital
Enrollment
80
Locations
1
Primary Endpoint
Perioperative transfusion rate (%)
Last Updated
5 years ago

Overview

Brief Summary

This study is to compare the outcomes of robotic-assisted laparoscopic radical prostatectomy (RARP) and laparoscopic radical prostatectomy (LRP) for prostate cancer treatment in terms of perioperative surgical, functional and oncological outcomes.

Detailed Description

Participants will either have robotic-assisted laparoscopic radical prostatectomy (RARP) or laparoscopic radical prostatectomy (LRP) as determined by the treating surgeon. All participants will undergo tests and questionnaires to determine urinary and erectile function, biopsies to determine perioperative surgical, functional and oncological outcomes. These assessments will be conducted pre-operatively, post-operatively and at certain follow-up time points up to 12 months.

Registry
clinicaltrials.gov
Start Date
January 1, 2019
End Date
December 31, 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adult men aged 18 years and over;
  • Undergoing RARP or LRP. prostatectomy for prostate cancer at Binh Dan Hospital;
  • Clinically suitable for radical prostatectomy (cT1-3, No, Mo);
  • Cognitively able to give written informed consent for participation;
  • Elective procedure.

Exclusion Criteria

  • The patient lacks the ability to consent for themselves;
  • Patients unwilling to undergo pre- and post-operative evaluation according to the protocol;

Outcomes

Primary Outcomes

Perioperative transfusion rate (%)

Time Frame: Up to 1 month after operation

The number of cases which will be transfused.

The console time

Time Frame: During the surgery

The time which surgeon spends on the robot console by minuite

The postoperative recovery parameters using Numeric Pain Rating Scale (NPRS),

Time Frame: Up to 3 month after surgery

The NPRS is a segmented numeric version of the visual analog scale (VAS) in which a respondent selects a whole number (0-10 integers) that best reflects the intensity of pain, in a total of 10 points, higher score means worse, with 0 means no pain and 10 is the worst pain. The mean score will be calculated to reflect the post-operative pain.

The rate of postoperative complications (including infections)

Time Frame: in day 3, day 7, and 1 month after surgery.

Percentage

PSA level in blood

Time Frame: 12 months post-operation

(mg/mL)

To assess postoperative hospital stay

Time Frame: Up to 1 month after surgery

(day)

Mean of blood loss

Time Frame: During the surgery

Milliliter

the rate of conversion to open surgery, the rate of intraoperative incidents (%),

Time Frame: Up to 1 weeks after the surgery.

Percentage

The drainage time

Time Frame: Up to 3 months after surgery

(day),

To assess urethral catheter time, urethral catheter time

Time Frame: Up to 3 months after surgery

(day)

The rate of positive surgical margins, extracapsular extension, seminal vesicle invasion, (5)perineural invasion, the number of lymph node yield and node involvement,

Time Frame: Up to 1 week after operation

Number of cases, based on the result of pathology.

To assess bowel movement recovery time,

Time Frame: Up to 1 week after surgery

(day)

local and regional recurrences on sonography

Time Frame: through study completion, an average of 1 year

including ultrasound when PSA rising or any indication of recurrent

local and regional recurrences, on MRI

Time Frame: through study completion, an average of 1 year

including MRI when PSA rising or any indication of recurrent

local and regional recurrences, on PET Scan

Time Frame: through study completion, an average of 1 year

including PET Scan, when PSA rising or any indication of recurrent

Number of blood units transfused

Time Frame: Up to 1 week after operation

Milliliter

Change of hemoglobin from baseline

Time Frame: Up to 1 week after operation

(mg/mL)

Secondary Outcomes

  • Evaluating the pre and postoperative lower urinary tract symptoms using Full score of International Prostate Symptoms Scores (IPSS)(12 months postoperative.)
  • The quality of life questionnaires and scoring using the the Short Form (36) Health Survey questionnaire(12 months postoperative)
  • Evaluating the pre and postoperative lower urinary tract symptoms using International Prostate Symptoms Scores (IPSS)(3 months postoperative)
  • Erectile function assessments questionnaires and scoring using Index of Erectile Function Questionnaire, IIEF5, full score(12 months postoperative)

Study Sites (1)

Loading locations...

Similar Trials